Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Breaking the Mucin Barrier: A New Affinity Chromatography-Mass Spectrometry Approach to Unveil Potential Cell Markers and Pathways Altered in Pseudomyxoma Peritonei.
Romero-Ruiz A, Granados-Rodríguez M, Bura FI, Valenzuela-Molina F, Rufián-Andújar B, Martínez-López A, Rodríguez-Ortiz L, Ortega-Salas R, Torres-Martínez M, Moreno-Serrano A, Castaño J, Michán C, Alhama J, Vázquez-Borrego MC, Arjona-Sánchez Á. Romero-Ruiz A, et al. Biol Proced Online. 2024 May 15;26(1):13. doi: 10.1186/s12575-024-00239-0. Biol Proced Online. 2024. PMID: 38750435 Free PMC article.
Undetectable circulating tumor DNA confirms the inability of pseudomyxoma peritonei to systemic dissemination.
Villarejo Campos P, Vázquez-Borrego MC, Martínez-Quintanilla J, Cabot D, Romero-Ruíz A, Granados-Rodríguez M, Bura FI, García-Arranz M, García-Olmo D, Arjona-Sánchez A. Villarejo Campos P, et al. Among authors: romero ruiz a. Eur J Surg Oncol. 2024 May 9;50(7):108395. doi: 10.1016/j.ejso.2024.108395. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 38735236
Intra-tumoural bromelain and N-acetylcysteine for recurrent and unresectable pseudomyxoma peritonei: phase I/II trial.
Rodríguez-Ortiz L, Vázquez-Borrego MC, Bura FI, Granados-Rodríguez M, Valenzuela-Molina F, Rufián-Andújar B, Martínez-López A, Ortega-Salas R, Espejo-Herrero JJ, Romero-Ruiz A, Arjona-Sánchez Á. Rodríguez-Ortiz L, et al. Among authors: romero ruiz a. Br J Surg. 2024 Mar 2;111(3):znae045. doi: 10.1093/bjs/znae045. Br J Surg. 2024. PMID: 38477594 Clinical Trial. No abstract available.
Antitumor effect of a small-molecule inhibitor of KRASG12D in xenograft models of mucinous appendicular neoplasms.
Vázquez-Borrego MC, Granados-Rodríguez M, Bura FI, Martínez-López A, Rufián-Andújar B, Valenzuela-Molina F, Rodríguez-Ortiz L, Haro-Yuste S, Moreno-Serrano A, Ortega-Salas R, Pineda-Reyes R, Michán C, Alhama J, Romero-Ruiz A, Arjona-Sánchez Á. Vázquez-Borrego MC, et al. Among authors: romero ruiz a. Exp Hematol Oncol. 2023 Dec 8;12(1):102. doi: 10.1186/s40164-023-00465-4. Exp Hematol Oncol. 2023. PMID: 38066554 Free PMC article.
Correction: Laparoscopic versus open approach for interval cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced epithelial ovarian cancer: a matched comparative study.
Durán-Martínez M, Gómez-Dueñas G, Rodriguez-Ortíz L, Sanchez-Hidalgo JM, Gordón-Suárez A, Casado-Adam Á, Rufián-Peña S, Valenzuela-Molina F, Rufián-Andujar B, Vázquez-Borrego MC, Romero-Ruiz A, Briceño-Delgado J, Arjona-Sánchez Á. Durán-Martínez M, et al. Among authors: romero ruiz a. Surg Endosc. 2024 Jan;38(1):471. doi: 10.1007/s00464-023-10576-y. Surg Endosc. 2024. PMID: 37935922 No abstract available.
Laparoscopic versus open approach for interval cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced epithelial ovarian cancer: a matched comparative study.
Durán-Martínez M, Gómez-Dueñas G, Rodriguez-Ortíz L, Sanchez-Hidalgo JM, Gordón-Suárez A, Casado-Adam Á, Rufián-Peña S, Valenzuela-Molina F, Rufián-Andujar B, Vázquez-Borrego MC, Romero-Ruiz A, Briceño-Delgado J, Arjona-Sánchez Á. Durán-Martínez M, et al. Among authors: romero ruiz a. Surg Endosc. 2024 Jan;38(1):66-74. doi: 10.1007/s00464-023-10508-w. Epub 2023 Oct 30. Surg Endosc. 2024. PMID: 37903884
Grazing livestock move by Lévy walks: Implications for soil health and environment.
Romero-Ruiz A, Rivero MJ, Milne A, Morgan S, Meo Filho P, Pulley S, Segura C, Harris P, Lee MR, Coleman K, Cardenas L, Whitmore AP. Romero-Ruiz A, et al. J Environ Manage. 2023 Nov 1;345:118835. doi: 10.1016/j.jenvman.2023.118835. Epub 2023 Aug 31. J Environ Manage. 2023. PMID: 37659361 Free article.
Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Long term oncologic outcomes from the international PSOGI registry.
Arjona-Sanchez A, Aziz O, Passot G, Salti G, Serrano A, Esquivel J, Van der Speeten K, Sommariva A, Kazi M, Shariff U, Martínez-Regueira F, Piso P, Yonemura Y, Turaga K, Sgarbura O, Avanish Saklani A, Tonello M, Rodriguez-Ortiz L, Vazquez-Borrego MC, Romero-Ruiz A, Glehen O; International Laparoscopic PSOGI Registry. Arjona-Sanchez A, et al. Among authors: romero ruiz a. Eur J Surg Oncol. 2023 Oct;49(10):107001. doi: 10.1016/j.ejso.2023.107001. Epub 2023 Aug 3. Eur J Surg Oncol. 2023. PMID: 37579618
Establishment of a desirable dose using neutral argon plasma to eradicate miliary peritoneal implants: A phase I/II controlled trial.
Pontes-García A, Martínez-López A, Rodríguez-Ortiz L, Valenzuela-Molina F, Rufián-Andújar B, Sánchez-Hidalgo JM, Casado-Adam A, Gordon-Suarez A, Rufián-Peña S, Vázquez-Borrego MC, Romero-Ruiz A, Arjona-Sánchez A. Pontes-García A, et al. Among authors: romero ruiz a. Eur J Surg Oncol. 2023 Sep;49(9):106978. doi: 10.1016/j.ejso.2023.07.004. Epub 2023 Jul 11. Eur J Surg Oncol. 2023. PMID: 37460370 Clinical Trial.
66 results